Containment Drugs Genotype Protein 
Delveinsight
DECEMBER 13, 2020
alcohol, certain drugs) and autoimmune diseases can also cause hepatitis. The first approved treatment for hepatitis C was a series of protein-based injections called recombinant interferon-alfa (IFNa). 2b) was developed to maintain a steady level of an active drug and reduce the frequency of administration.
The Pharma Data
APRIL 14, 2021
Accelerated Approval Granted for Locally Advanced or Metastatic Urothelial Cancer Following a Platinum-Containing Chemotherapy and a PD-1/PD-L1 Inhibitor –. – New Indication Marks Second FDA Approval for Trodelvy in 2021 –. Premedicate with a two or three drug combination regimen (e.g., FOSTER CITY, Calif.–(BUSINESS
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
APRIL 7, 2021
Food and Drug Administration (FDA) has granted full approval to Trodelvy ® (sacituzumab govitecan-hziy) for adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies, at least one of them for metastatic disease. FOSTER CITY, Calif.–(BUSINESS
The Pharma Data
MARCH 25, 2021
SG is a first-in-class therapy targeting Trop-2, a protein frequently expressed in multiple types of epithelial tumors, such as TNBC, where high expression is associated with poor survival and relapse. Premedicate with a 2- or 3-drug combination regimen (e.g., More information about ASCENT is available at [link].
XTalks
SEPTEMBER 15, 2020
In addition to the vaccine, the company is also developing an investigational drug called Remygen for the regeneration of endogenous insulin production and to improve hormonal response to hypoglycemia; trials to test the treatment are currently ongoing in patients that have been living with type 1 diabetes for more than five years.
Expert insights. Personalized for you.
52 
Let's personalize your content